JP7366041B2 - ダニ媒介性回帰熱（ｔｂｒｆ）に対する種特異的抗原配列および使用方法 - Google Patents

ダニ媒介性回帰熱（ｔｂｒｆ）に対する種特異的抗原配列および使用方法 Download PDF

Info

Publication number
JP7366041B2
JP7366041B2 JP2020546964A JP2020546964A JP7366041B2 JP 7366041 B2 JP7366041 B2 JP 7366041B2 JP 2020546964 A JP2020546964 A JP 2020546964A JP 2020546964 A JP2020546964 A JP 2020546964A JP 7366041 B2 JP7366041 B2 JP 7366041B2
Authority
JP
Japan
Prior art keywords
seq
tbrf
amino acid
sample
borrelia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020546964A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021516340A5 (https=
JPWO2019173569A5 (https=
JP2021516340A (ja
Inventor
シャー・ヨツナ・エス．
リウ・ソング
Original Assignee
アイデイー－フイツシユ・テクノロジー・インコーポレーテツド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アイデイー－フイツシユ・テクノロジー・インコーポレーテツド filed Critical アイデイー－フイツシユ・テクノロジー・インコーポレーテツド
Publication of JP2021516340A publication Critical patent/JP2021516340A/ja
Publication of JP2021516340A5 publication Critical patent/JP2021516340A5/ja
Publication of JPWO2019173569A5 publication Critical patent/JPWO2019173569A5/ja
Application granted granted Critical
Publication of JP7366041B2 publication Critical patent/JP7366041B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/6857—Antibody fragments
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/20—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2020546964A 2018-03-09 2019-03-07 ダニ媒介性回帰熱（ｔｂｒｆ）に対する種特異的抗原配列および使用方法 Active JP7366041B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15/916,717 2018-03-09
US15/916,717 US10718767B2 (en) 2018-03-09 2018-03-09 Species specific antigen sequences for tick-borne relapsing fever (TBRF) and methods of use
PCT/US2019/021113 WO2019173569A1 (en) 2018-03-09 2019-03-07 Species specific antigen sequences for tick-borne relapsing fever (tbrf) and methods of use

Publications (4)

Publication Number Publication Date
JP2021516340A JP2021516340A (ja) 2021-07-01
JP2021516340A5 JP2021516340A5 (https=) 2022-03-15
JPWO2019173569A5 JPWO2019173569A5 (https=) 2022-03-15
JP7366041B2 true JP7366041B2 (ja) 2023-10-20

Family

ID=67843846

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020546964A Active JP7366041B2 (ja) 2018-03-09 2019-03-07 ダニ媒介性回帰熱（ｔｂｒｆ）に対する種特異的抗原配列および使用方法

Country Status (5)

Country Link
US (2) US10718767B2 (https=)
EP (1) EP3762725B1 (https=)
JP (1) JP7366041B2 (https=)
CA (1) CA3092156A1 (https=)
WO (1) WO2019173569A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220229055A1 (en) * 2021-01-15 2022-07-21 Id-Fish Technology, Inc. Species-specific antigen sequences for tick-borne relapsing fever (tbrf) and methods of use
BR112023021860A2 (pt) * 2021-04-23 2023-12-19 Id Fish Tech Inc Composição, método para detectar infecção por uma ou mais espécies de babesia, método para detectar infecção espécie-específica por b. microti ou b. duncani e vetor

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001078789A (ja) 1995-01-19 2001-03-27 Gen Probe Inc ライム病関連ボレリアに対する核酸増幅オリゴヌクレオチドおよびプローブ
US20130210651A1 (en) 2007-09-07 2013-08-15 The Regents Of The University Of California Borrelia Diagnostics and Screening Methods
US20190093149A1 (en) 2017-09-27 2019-03-28 The United States Of America, As Represented By The Secretary Of Agriculture Assays for detecting multiple tick-borne pathogens

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE142888T1 (de) * 1990-03-05 1996-10-15 Us Health Antigen-wirkende proteine von borrelia burgdorferi
WO2011163258A2 (en) * 2010-06-21 2011-12-29 Pharmason Labs, Inc. Compositions and methods for diagnosing and monitoring disease and treatment via antigen-specific molecules
HK1244534A1 (zh) 2014-10-07 2018-08-10 The Research Foundation For The State University Of New York 重组疏螺旋体蛋白及其使用方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001078789A (ja) 1995-01-19 2001-03-27 Gen Probe Inc ライム病関連ボレリアに対する核酸増幅オリゴヌクレオチドおよびプローブ
US20130210651A1 (en) 2007-09-07 2013-08-15 The Regents Of The University Of California Borrelia Diagnostics and Screening Methods
US20190093149A1 (en) 2017-09-27 2019-03-28 The United States Of America, As Represented By The Secretary Of Agriculture Assays for detecting multiple tick-borne pathogens

Non-Patent Citations (14)

* Cited by examiner, † Cited by third party
Title
Ai Takano，Characterization of reptile-associated Borrelia sp. in the vector tick, Amblyomma geoemydae, and its association with Lyme disease and relapsing fever Borrelia spp.，Environmental Microbiology Reports，2011年，Vol.3 No.5，Page.632-637
Anna M. Christensen，Diagnosis and Management of Borrelia turicatae Infection in Febrile Soldier, Texas, USA，Emerging Infectious Diseases，2017年05月，Vol.23 No.5，Page.883-884
Curtis L. Fritz，Isolation and Characterization of Borrelia hermsii Associated with Two Foci of Tick-Borne Relapsing Fever in California，JOURNAL OF CLINICAL MICROBIOLOGY，2004年03月，Vol.42 No.3，Page.1123-1128
Hannah K. Wilder，Case Report: A Retrospective Serological Analysis Indicating Human Exposure to Tick-Borne Relapsing Fever Spirochetes in Texas，PLoS Negl Trop Dis，2015年04月09日，Vol.9 No.4，Page.e0003617
Job E. Lopez，A Novel Surface Antigen of Relapsing Fever Spirochetes Can Discriminate between Relapsing Fever and Lyme Borreliosis，CLINICAL AND VACCINE IMMUNOLOGY，2010年04月，Vol.17 No.4，Page.564-571
Job E. Lopez，Sequence Analysis and Serological Responses against Borrelia turicatae BipA, a Putative Species-Specific Antigen，PLoS Negl Trop Dis，2013年09月19日，Vol.7 No.9，Page.e2454
Jyotsna S. Shah，Line Immunoblot Assay for Tick-Borne Relapsing Fever and Findings in Patient Sera from Australia, Ukraine and the USA，Healthcare，2019年10月21日，Vol.7 No.4，Page.121
R T Trevejo，An interstate outbreak of tick-borne relapsing fever among vacationers at a Rocky Mountain cabin，The American Journal of Tropical Medicine and Hygiene，1998年，Vol 58 No.6，Page.743-747
Rafal Tokarz，A multiplex serologic platform for diagnosis of tick-borne diseases，SCIENTIFIC REPORTS，2018年02月16日，Vol.8，Page.3158
ROGER N. PICKEN，Polymerase Chain Reaction Primers and Probes Derived from Flagellin Gene Sequences for Specific Detection of the Agents of Lyme Disease and North American Relapsing Fever，JOURNAL OF CLINICAL MICROBIOLOGY，1992年01月，Vol.30 No.1，Page.99-114
Song Liu，Pilot Study of Immunoblots with Recombinant Borrelia burgdorferi Antigens for Laboratory Diagnosis of Lyme Disease，Healthcare，2018年08月14日，Vol.6 No.3，Page.99
Stefanie B. Campbell，Evaluating the risk of tick‐borne relapsing fever among occupational cavers-Austin, TX, 2017，Zoonoses Public Health，2019年05月31日，Vol.66 No.6，Page.579-586
増田剛太，四類感染症 回帰熱，日本医師会雑誌，2004年12月05日，Vol.132 No.12，Page.116-117,383
高野愛，回帰熱病原体Borrelia miyamotoiの検出法の確立検証、およびIxodes属ダニからの病原体検出への応用，衛生動物，2013年06月15日，Vol.64 No.2，Page.113

Also Published As

Publication number Publication date
EP3762725A4 (en) 2022-03-09
US20190277847A1 (en) 2019-09-12
EP3762725B1 (en) 2024-10-23
CA3092156A1 (en) 2019-09-12
US20200348301A1 (en) 2020-11-05
WO2019173569A1 (en) 2019-09-12
US11353457B2 (en) 2022-06-07
US10718767B2 (en) 2020-07-21
EP3762725A1 (en) 2021-01-13
JP2021516340A (ja) 2021-07-01

Similar Documents

Publication Publication Date Title
JP5759724B2 (ja) エーリキア・カニス（Ｅｈｒｌｉｃｈｉａｃａｎｉｓ）のＤＩＶＡ（ワクチン接種した動物から感染した動物を区別する）
Manish et al. Brucellosis: An updated review of the disease
JP7366041B2 (ja) ダニ媒介性回帰熱（ｔｂｒｆ）に対する種特異的抗原配列および使用方法
US8440208B2 (en) Chlamydial antigens as reagents for diagnosis and treatment of chlamydial infection and disease
US8338566B2 (en) Characterization of BBK07 antigen of Borrelia burgdorferi and methods of use
Mol Laboratorial diagnosis of animal brucellosis
US20130115639A1 (en) Method for detecting a salmonella infection
JP2024517646A (ja) Ｂａｂｅｓｉａ組換えタンパク質を使用するＢａｂｅｓｉａの診断
da Silva Mol et al. Laboratorial diagnosis of animal brucellosis
Skinner-Taylor et al. Antibody profile to Borrelia burgdorferi in veterinarians from Nuevo León, Mexico, a non-endemic area of this zoonosis
EP2396655B1 (de) VORRICHTUNG ZUM SEROLOGISCHEN NACHWEIS VON YERSINIEN-INFEKTIONEN UND/ODER DEREN FOLGEERKRANKUNGEN SOWIE VERWENDUNG DER PROTEINE MyfA UND PsaA VON Y.ENTEROCOLITICA UND Y.PSEUDOTUBERCULOSIS ALS REKOMBINANTE ANTIGENE
JP2024505438A (ja) ダニ媒介性回帰熱（ｔｂｒｆ）の種特異的抗原配列及び利用法
MONTES DE OCA JIMENEZ et al. The Use of Peptides in Veterinary Serodiagnosis of Infectious Diseases: A Review
JP2026501151A (ja) 組換えタンパク質を用いたバルトネラの診断
Muralidharan Development of immunological assays to assist the control of spotty liver disease in layer hens
WO2024091264A1 (en) Chimeric recombinant proteins and recombinant protein panels for the diagnosis of lyme disease in animals and humans
BR102024000617A2 (pt) Kit, método para diagnóstico da brucelose bovina, e usos
Gröhn et al. Adaption of Elisa for the Detection oCampylobacter Antibodies and its Application in Seroepidemiological Studies in Sheep and Cattle Herds
TWI294967B (en) Protein microarray for detecting pathogenic antigen inducing fever
Magnarelli et al. Serum antibodies to whole-cell and recombinant antigens of Borrelia burgdorferi in cottontail rabbits
EP3695228A1 (en) Chlamydia suis diagnosis
Elton Construction and Optimization of an Interferon Gamma Dipstick Assay for the Detection of Antigen-Specific Cell Mediated Immune Responses
CA3148718A1 (en) Bovine pathogen array
Minda Asfaw Geresu et al. A review on diagnostic methods of brucellosis.
Inman et al. Cattle immunology: vaccination and immunological testing

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220307

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220307

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230124

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230410

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230713

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230919

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20231010

R150 Certificate of patent or registration of utility model

Ref document number: 7366041

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150